U.S. Entertainment Stock News

Indivior Pharmaceuticals (INDV) is back on investors' radars after a busy stretch that combined strong Q1 2026 results, a raised full year revenue outlook, and a fresh accelerated share repurchase plan. See our latest analysis for Indivior Pharmaceuticals. The recent Q1 beat, raised 2026 guidance, and the new accelerated share repurchase agreement have all coincided with strong momentum, with a 27.93% 1 month share price return and a very large 1 year total shareholder return that far...

Allegiant Travel Company recently reported first-quarter 2026 results showing revenue of US$732.43 million and net income of US$42.48 million, with basic earnings per share from continuing operations of US$2.30, all higher than a year earlier despite rising fuel costs and lower system capacity. The company also delivered a record 14.9% adjusted operating margin and strong unit revenue growth while maintaining US$1.20 billions in liquidity, highlighting how its focus on peak-period flying,...

Alphatec Holdings, Inc. recently confirmed it would report Q1 2026 results after the market close on May 5, 2026, followed by an earnings call, while also preparing for its June 10, 2026 Annual Meeting where shareholders will vote on director elections, auditor ratification, and new equity plans. The company is highlighting a pay-for-performance compensation approach and expanded equity incentives at a time when investors are closely watching how ongoing revenue growth interacts with...

Lufax Holding (NYSE:LU) is back in focus after securities class action lawsuits followed its removal of auditor PwC. The auditor had questioned undisclosed related party transactions and prior audit opinions, putting governance and transparency under scrutiny. See our latest analysis for Lufax Holding. The recent lawsuits and auditor concerns have come after a long weak patch for investors, with a 30 day share price return of 5.91% offering only a short break. This followed a 90 day share...

In late April 2026, Benchmark Electronics reported first-quarter 2026 results showing sales of US$677.28 million and net income of US$13.02 million, while issuing second-quarter revenue guidance of US$700 million to US$740 million. The company also raised its full-year 2026 revenue growth outlook to 9%–10%, underscoring management’s confidence in momentum across medical, semiconductor capital equipment, and advanced computing and communications end markets. We’ll now consider how the...

PPL Corporation is scheduled to report its March 2026 quarter earnings on May 8, 2026, with analysts previously expecting a year-over-year increase and a positive Earnings ESP, while its Kentucky utilities are working with X-energy to evaluate Xe-100 small modular nuclear reactors as a potential clean, reliable power source. This combination of anticipated earnings strength and early-stage nuclear collaboration underscores how PPL is increasingly aligning its regulated utility footprint with...

Edesa Biotech, Inc. ( NASDAQ:EDSA ) insiders who purchased shares in the last 12 months were richly rewarded last week...

Syndax Pharmaceuticals, Inc. ( NASDAQ:SNDX ) shareholders are probably feeling a little disappointed, since its shares...

We feel now is a pretty good time to analyse AmpliTech Group, Inc.'s ( NASDAQ:AMPG ) business as it appears the company...

While L.B. Foster Company ( NASDAQ:FSTR ) shareholders have had a good week with the stock up 15%, insiders can't say...

UFP Technologies has reported its first-quarter 2026 results, with sales rising to US$154.2 million and net income edging up to US$17.5 million, alongside slightly higher basic and diluted earnings per share versus a year earlier. Beneath these headline figures, growth in medical sales, a pullback in non-medical revenue, and new Dominican Republic facilities highlight the company’s sharpening focus on MedTech and capacity to support areas such as robotic surgery and safe patient...

TransMedics Group (TMDX) has drawn fresh attention after agreeing to invest in Germany based PAD Aviation to build a dedicated organ transplant logistics network in Europe, extending its Organ Care System reach. See our latest analysis for TransMedics Group. The stock has recently given back ground, with a 1 week share price return of a 10.21% decline and a 3 month share price return of a 28.47% decline. This comes even as product launches in Canada and progress on organ preservation trials...

Robert Half Inc. recently reported first-quarter 2026 results showing year-over-year declines in net income and diluted earnings per share from continuing operations, while also declaring a quarterly dividend of US$0.5900 per share payable on June 15, 2026, to shareholders of record on May 22, 2026. Alongside these results, the company issued second-quarter 2026 guidance pointing to lower adjusted revenues than the prior year, highlighting ongoing operational headwinds even as it maintains...

Earnings shock and governance changes put KE Holdings in focus KE Holdings (BEKE) has drawn fresh attention after reporting a sharp drop in net income to RMB432 million from RMB2,750 million, along with steep pressure in new home transaction services and rising concerns about China’s housing market recovery. See our latest analysis for KE Holdings. The stock’s recent 1 month share price return of 17.89% and 7 day gain of 8.92%, against a 1 year total shareholder return decline of 14.91% and a...

Tenable Holdings (TENB) is back in focus after first quarter 2026 earnings, where revenue and profitability were ahead of its own expectations and full year guidance for both metrics was raised. See our latest analysis for Tenable Holdings. Despite the upbeat earnings and raised guidance, Tenable’s recent share price performance has been mixed, with a 30 day share price return of 18.5% but a 1 year total shareholder return decline of 33.4%. This suggests that optimism is rebuilding from a...

Fulton Financial (FULT) is back in focus after the bank completed a $300 million fixed to floating rate subordinated notes offering. This refinancing move reshapes its capital structure and long term funding profile. See our latest analysis for Fulton Financial. These refinancing plans and the recent share buyback sit against a mixed price backdrop. The 1 month share price return is 3.26%, but there has been a 1 day decline of 1.94%. Meanwhile, the 1 year total shareholder return of 29.03%...

Twist Bioscience recently reported past second-quarter 2026 results, with sales rising to US$110.72 million from US$92.79 million a year earlier, while net loss widened to US$44.02 million and loss per share increased to US$0.71. Alongside earnings, Twist launched its Complex Genes offering, a step that materially broadens its ability to synthesize highly engineered, difficult-to-manufacture DNA sequences for advanced therapeutics and AI-driven drug discovery. Next, we’ll examine how the...

NVR (NVR) stock is back in focus after first quarter 2026 results showed lower profit and revenue, weaker homebuilding margins, and a drop in settlements, with earnings missing analyst expectations and pressuring sentiment. See our latest analysis for NVR. The weaker first quarter results and earnings miss have gone hand in hand with a 23.66% 90 day share price return decline and a 16.17% fall in 1 year total shareholder return, suggesting momentum has cooled after a modest 3 year gain. If...

Tennant (TNC) is back in focus after Q1 2026 results showed sales of US$297.9 million and non-GAAP EPS ahead of analyst expectations, alongside a larger share repurchase capacity of up to 15%. See our latest analysis for Tennant. At a share price of US$81.95, Tennant has seen a 17.34% 1 month share price return and a 10.80% year to date share price return. The 1 year total shareholder return of 16.32% points to building momentum as investors weigh Q1 earnings, the expanded buyback capacity...

In late April 2026, Nuvalent announced a multi-year collaboration with Guardant Health to use Guardant’s Infinity tissue and liquid biopsy platform to support clinical development, potential companion diagnostics, and future global commercialization of Nuvalent’s oncology pipeline. This partnership reinforces how precision diagnostics are becoming integral to drug development, tying Guardant’s testing capabilities directly to emerging targeted cancer therapies and potential regulatory...

Commvault Systems recently reported fourth-quarter 2026 revenue of US$311.69 million and full-year revenue of US$1.18 billion, issued fiscal 2027 guidance calling for US$1.30–US$1.31 billion in total revenue, completed a major share repurchase program, and expanded its Commvault Cloud platform availability to Google Cloud Marketplace. These developments, alongside growing annual recurring revenue and upcoming presentations at Google Cloud Next 2026 and the GEOINT Symposium 2026, highlight...

Smurfit Westrock Plc recently reported past first-quarter 2026 results showing sales of US$7,712 million, broadly flat year-on-year, while net income dropped to US$65 million and earnings per share fell to US$0.12. Despite the sharp profit compression and operational challenges, the company affirmed a quarterly dividend of US$0.4523 per share and outlined mill and site closures alongside a review of its London Stock Exchange listing. We’ll now examine how the sharp drop in quarterly profit...

ICU Medical stock snapshot after recent share performance ICU Medical (ICUI) has drawn fresh attention after a weak run in the stock, with negative returns over the past week, month and past 3 months, focusing investors on how its fundamentals compare with recent price action. See our latest analysis for ICU Medical. At a share price of $118.67, ICU Medical has experienced short-term share price pressure, with a 21.25% decline over three months contributing to a 5-year total shareholder...

Deluxe (DLX) has moved into focus after announcing a partnership with MRI Software that makes it the official processing partner for MRI’s rent payment solution, expanding its role in property management payments. See our latest analysis for Deluxe. The new MRI partnership and recent technology awards come on top of strong share price momentum, with a 30-day share price return of 12.69% and a 1-year total shareholder return of 118.64%. However, the 5-year total shareholder return of a 13.84%...